NCT00933452View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Healthy
Interventions
DRUG

duloxetine

30mg, oral administer; step 1: single dose; step 2: multiple dose, 7 days

DRUG

duloxetine

15mg, oral administer

DRUG

duloxetine

60mg, oral administer; step 1: generic duloxetine; step 2: Innovator duloxetine

Trial Locations (1)

200030

Shanghai Mental Health Center, Shanghai

Sponsors
All Listed Sponsors
collaborator

Jiangsu Nhwa Pharmaceutical Co., Ltd.

INDUSTRY

lead

Shanghai Mental Health Center

OTHER

NCT00933452 - A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects | Biotech Hunter | Biotech Hunter